VasoDynamics is a UK-based pharmaceutical development company with a pipeline of drugs in development to address the side-effects associated with cancer therapies. We are a young company with experienced and diversified executives and a shared vision to improve the standard of cancer care globally. With mounting cost pressures facing healthcare payers all over the world, we are developing cost-efficient medicines which aim to prevent the debilitating, and often dose-limiting, complications of cancer therapy such as skin/mucosa damage and hair-loss. We take great pride in our culture of scientific and development rigour, and our programmes are based on robust science from world-leading research bodies.
Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.Contact Marco